University of Oxford scientists launch first human vaccine trials for deadly Nipah virus Ruchika Sharma16 Jan 2024 11:43 AM ISTUK: Scientists at the University of Oxford in the UK have launched first-in-human vaccine trials for the deadly Nipah virus which impacts many...
Yet to take decision on roll-out of HPV vaccination against cervical cancer: Govt Ruchika Sharma15 Jan 2024 12:30 PM ISTNew Delhi: The Union Health Ministry has said it has yet to take a decision on the roll-out of HPV vaccination against cervical cancer in the country....
Two doses of recombinant zoster vaccine provides strong protection over 4 years even in immunocompromised patients Dr Riya Dave11 Jan 2024 7:30 PM ISTRecent research evaluating the long-term effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster, commonly known as shingles, has...
Indian Immunologicals starts work on veterinary vaccine facility in Hyderabad Ruchika Sharma31 Dec 2023 1:00 PM ISTThe proposed facility has a capacity of 150 million doses per annum of FMD vaccine or FMD plus HS vaccine each.
High-Dose Recombinant Vaccine may Enhance Protection Against Influenza among Adults Aged 50-64 Dr.Niharika Harsha B29 Dec 2023 1:15 AM ISTIn a groundbreaking cluster-randomized observational study, Kaiser Permanente Northern California has unveiled compelling evidence supporting the...
Biological E Gets CDSCO Panel Nod to study safety of XBB 1.5-RBD Subunit Covid-19 Vaccine in 5-80 years old Dr. Divya Colin28 Dec 2023 6:00 PM ISTNew Delhi: The drug major Biological E has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
WHO Adds R21/Matrix-M Malaria Vaccine to Prequalified List Jacinthlyn Sylvia24 Dec 2023 8:45 PM ISTMalaria inflicts a disproportionate burden on children in the African Region, taking up nearly half a million lives annually. Global statistics from...
WHO adds SII-Oxford University Malaria vaccine to its list of prequalified vaccines Ruchika Sharma23 Dec 2023 3:00 PM ISTThe prequalification of the world's second malaria vaccine, developed by Oxford University and manufactured by Serum Institute of India, is poised to...
USFDA grants priority review to Merck investigational 21-valent Pneumococcal Conjugate Vaccine specifically designed to protect adults Ruchika Sharma21 Dec 2023 3:47 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Maternal influenza vaccination during pregnancy may protect infant in first few months of life: JAMA Dr Riya Dave19 Dec 2023 11:30 PM ISTA recent study exploring the impact of maternal influenza vaccination during pregnancy has shown promising outcomes in reducing influenza-related...
Melanoma vaccine could be available by 2025: Moderna CEO Ruchika Sharma17 Dec 2023 1:00 PM ISTWashington: Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two...
Japan accepts GSK Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk Ruchika Sharma14 Dec 2023 10:00 AM ISTLondon: GSK plc has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a regulatory application to extend...
